We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

150 hedge funds and large institutions have $2.87B invested in Legend Biotech in 2022 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

208% more call options, than puts

Call options by funds: $47.7M | Put options by funds: $15.5M

55% more capital invested

Capital invested by funds: $1.85B → $2.87B (+$1.02B)

45% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 22

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

6% more funds holding

Funds holding: 141 → 150 (+9)

0.39% more ownership

Funds ownership: 16.7% → 17.09% (+0.39%)

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

Holders
150
Holders Change
+9
Holders Change %
+6.38%
% of All Funds
2.53%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
32
Increased
50
Reduced
50
Closed
22
Calls
$47.7M
Puts
$15.5M
Net Calls
+$32.2M
Net Calls Change
+$25.8M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$179M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$32M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$24M
4
ITP
Iron Triangle Partners
Connecticut
+$20.9M
5
SC
Samlyn Capital
New York
+$19.2M

Top Sellers

1
HA
HHLR Advisors
Cayman Islands
-$106M
2
BBA
Baker Bros. Advisors
New York
-$48.7M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$25.9M
4
PA
Perceptive Advisors
New York
-$22.4M
5
CII
Capital International Inc
California
-$22.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$367M +$179M +4,239,041 +175%
HA
2
HHLR Advisors
Cayman Islands
$244M -$106M -2,500,000 -36%
BlackRock
3
BlackRock
New York
$173M +$4.29M +101,702 +3%
Capital International Investors
4
Capital International Investors
California
$167M +$9.85M +233,229 +8%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$143M -$56.2K -1,330 -0.1%
Capital World Investors
6
Capital World Investors
California
$132M +$7.51M +177,849 +8%
Federated Hermes
7
Federated Hermes
Pennsylvania
$116M +$38.2K +905 +0%
Artisan Partners
8
Artisan Partners
Wisconsin
$93.9M -$3.19M -75,569 -4%
JJ
9
Johnson & Johnson
New Jersey
$89.6M – – –
AllianceBernstein
10
AllianceBernstein
Tennessee
$80.6M -$25.9M -613,155 -29%
Hudson Bay Capital Management
11
Hudson Bay Capital Management
Connecticut
$69.2M -$950K -22,500 -2%
CII
12
Capital International Inc
California
$68M -$22.2M -526,619 -30%
MICM
13
Matthews International Capital Management
California
$67.2M +$5.14M +121,800 +11%
Adage Capital Partners
14
Adage Capital Partners
Massachusetts
$66M +$16.5M +390,000 +48%
WP
15
Woodline Partners
California
$64.4M – – –
APM
16
Avidity Partners Management
Texas
$55M -$4.01M -95,000 -9%
PBA
17
Paradigm Biocapital Advisors
New York
$53.8M +$6.2M +146,868 +18%
BBA
18
Baker Bros. Advisors
New York
$47.1M -$48.7M -1,152,341 -57%
Lord, Abbett & Co
19
Lord, Abbett & Co
New Jersey
$41.7M +$32M +758,179 New
State Street
20
State Street
Massachusetts
$38.9M +$1.07M +25,437 +4%
BG
21
Bellevue Group
Switzerland
$34.7M -$1.25M -29,630 -4%
BA
22
Bridgewater Associates
Connecticut
$31.4M +$1.2M +28,381 +5%
T. Rowe Price Associates
23
T. Rowe Price Associates
Maryland
$31.2M +$24M +567,155 New
Manulife (Manufacturers Life Insurance)
24
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$27.4M +$1.15M +27,280 +6%
ITP
25
Iron Triangle Partners
Connecticut
$27.2M +$20.9M +495,329 New
1
2 3 4 5

LEGN Hedge Fund Activity: Q2 2022 in Review

150 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q2 2022, worth a combined $2.87B — up 55% from $1.85B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new LEGN positions and 22 closed out — a net gain of 10 holders — while 50 added to existing stakes and 50 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $179M. The largest seller was HHLR Advisors, cutting an estimated $106M.

  • 150 institutional investors held Legend Biotech (LEGN) as of Q2 2022, up from 141 in Q1 2022.
  • Funds reported $2.87B of Legend Biotech stock for Q2 2022, up 55% quarter-over-quarter.
  • 32 funds opened new Legend Biotech positions in Q2 2022 and 22 closed out, a net change of +10 holders.
  • The largest Legend Biotech buyer in Q2 2022 was Fidelity Investments, an estimated $179M added.
  • The largest Legend Biotech seller in Q2 2022 was HHLR Advisors, an estimated $106M sold.

Based on aggregated 13F filings for Q2 2022.